Report me for selling fake medicine? Why are you crying when your illness relapses?

"After this acquisition is successful, will Novartis take over the management of Antai Pharmaceutical Group?"

Reporters threw out question after question, all wanting to get first-hand information.

"We at Novartis do want to cooperate with Antai Pharmaceutical Group."

"We are also very interested in Mr. Chen's new drug patent, as it is a drug patent that can affect the whole world."

"However, Mr. Chen has his own development plans. We are unable to cooperate on patents for the time being, but we will explore other areas of collaboration."

Anna answered first.

It would be more appropriate for her to talk about these things.

Admit it openly so that it won't affect Novartis's stock price.

If someone else had exposed the information, people might have thought that Novartis was hiding it, which would definitely not be an advantage and would have affected the stock price.

Therefore, she responded first, and her answer was very meaningful.

First, he highly recognized Chen Xuan's new drug patent, and then expressed that there was no way to cooperate.

Everyone could understand what this meant, which was that Novartis wanted to acquire the patent for the new drug, but was directly rejected by Chen Xuan.

But at the same time, she also said that the two sides could carry out other cooperation to show the outside world the friendly relationship between the two sides.

It doesn’t matter what the two groups can cooperate on, but what matters is that the relationship between the two sides is good.

Changfeng Group and AbbVie were both rejected by Chen Xuan, and in the end there was no cooperation.

Novartis was also rejected this time, but there is cooperation in other areas. Doesn’t this mean that it has more advantages than pharmaceutical companies such as AbbVie?

Being able to sit on the CEO position, Anna is definitely not just a vase.

In just a few words, the disadvantage was turned into an advantage.

"Hiss, I didn't expect Novartis to be rejected too."

"I thought that if Anna came in person, Chen Xuan would not refuse."

"I wonder what price Anna offered? Is it higher than Abovi? It shouldn't be lower, right?"

"Why can't Chen Xuan refuse? Didn't he say long ago that he wanted to independently develop drugs? He would only consider transferring the patent when forced to do so."

"It seems Novartis still has a bigger advantage. At least AbbVie didn't get anything, but Novartis can still continue its cooperation with Aetna Pharmaceuticals."

"Of course. Don't you see how charming Anna is? Which man wouldn't be tempted? I don't think Chen Xuan can resist her charm either."

"Stop talking nonsense. I always feel that Anna admires Chen Xuan very much. Maybe she is even pursuing him."

Many people were surprised by Anna's answer.

They originally thought that since Novartis had personally taken action and was very sincere, they should be able to successfully acquire the company this time.

After all, Chen Xuan and Anna had worked together once before, and they knew each other quite well.

Having experience in cooperation should make it easier for both parties to reach cooperation, which is an advantage that no one else has.

Moreover, after trading the drug formula patent, he would often help Novartis with clinical trials, indicating that the cooperative relationship between the two parties has always been very good.

Unexpectedly, even Novartis was rejected.

This also reminded everyone of what he said at the beginning, that he had no intention of transferring the patent for the new drug.

Unless he is forced by the situation or by others, he will independently develop new drugs and will not choose to transfer the patent.

It was not until this moment that everyone understood the meaning of this sentence.

Even if tens of billions of dollars were placed in front of Chen Xuan, he would remain unmoved and continue to insist on promoting the independent launch of new drugs.

for this.

Countless people couldn't help but cheer.

They are most worried that the slippery road will successfully acquire the new drug formula.

No one wants to see new drugs fall into the hands of foreign companies again, nor do they want them to be obtained by other pharmaceutical companies.